O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Return
13.05%
This Quarter Return
+37.59%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.86B
AUM Growth
+$1.15B
(+17%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
39.67%
Holding
137
New
17
Increased
32
Reduced
42
Closed
9
Top Buys
| 1 |
AGN
ALLERGAN INC
AGN
|
$186M |
| 2 |
Intuitive Surgical
ISRG
|
$115M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$60.8M |
| 4 |
AbbVie
ABBV
|
$53.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$45.4M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$83.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
$58.4M |
| 4 |
UnitedHealth
UNH
|
$56.5M |
| 5 |
CELG
Celgene Corp
CELG
|
$53.8M |
Sector Composition
| 1 | Healthcare | 86.06% |
| 2 | Technology | 0.09% |
| 3 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$102B
| $11.3M | 0.14% |
160,000
-95,000
| -37% | -$6.72M |
|
|
MRGE
77
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $11.3M | 0.14% |
4,628,500
| – | – |
|
|
ATRS
78
DELISTED
Antares Pharma, Inc.
ATRS
| $11.2M | 0.14% |
3,213,900
-1,378,100
| -30% | -$4.82M |
|
79
InspireMD
NSPR
$102M
| $10.4M | 0.13% |
1
| – | – |
|
80
Exelixis
EXEL
$10.1B
| $10.2M | 0.13% |
2,888,000
-6,501,000
| -69% | -$23M |
|
81
DaVita
DVA
$9.69B
| $9.85M | 0.12% |
143,000
| – | – |
|
82
Xencor
XNCR
$597M
| $9.4M | 0.12% |
801,700
+99,100
| +14% | +$1.16M |
|
|
GEVA
83
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $9.22M | 0.11% |
111,100
-18,900
| -15% | -$1.57M |
|
|
RDHL
84
Redhill Biopharma
RDHL
$2.82M
| $8.9M | 0.11% |
+632
| New | +$8.9M |
|
|
FRX
85
DELISTED
FOREST LABORATORIES INC
FRX
| $8.67M | 0.11% |
94,000
-45,000
| -32% | -$4.15M |
|
|
86
UnitedHealth
UNH
$281B
| $8.36M | 0.1% |
102,000
-689,000
| -87% | -$56.5M |
|
|
VIRX
87
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $7.93M | 0.1% |
+5,714
| New | +$7.93M |
|
88
Vanda Pharmaceuticals
VNDA
$274M
| $7.51M | 0.09% |
462,400
-527,600
| -53% | -$8.57M |
|
|
VCRA
89
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $7.31M | 0.09% |
447,500
| – | – |
|
90
Fate Therapeutics
FATE
$112M
| $6.75M | 0.08% |
692,900
-9,100
| -1% | -$88.6K |
|
91
Abbott
ABT
$231B
| $6.7M | 0.08% |
174,000
-131,000
| -43% | -$5.05M |
|
|
CBST
92
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $6.58M | 0.08% |
90,000
| – | – |
|
|
BLUE
93
DELISTED
bluebird bio
BLUE
| $6.57M | 0.08% |
+22,311
| New | +$6.57M |
|
|
CVD
94
DELISTED
COVANCE INC.
CVD
| $6.55M | 0.08% |
63,000
+4,000
| +7% | +$416K |
|
95
Zoetis
ZTS
$67.9B
| $6.4M | 0.08% |
221,000
-58,000
| -21% | -$1.68M |
|
|
RPTP
96
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $6M | 0.07% |
+600,000
| New | +$6M |
|
|
GWPH
97
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.67M | 0.07% |
95,500
-224,700
| -70% | -$13.3M |
|
98
Curis
CRIS
$21.4M
| $5.5M | 0.07% |
19,501
| – | – |
|
|
QCOR
99
DELISTED
QUESTCOR PHARMA INC
QCOR
| $5.19M | 0.06% |
80,000
| – | – |
|
100
Supernus Pharmaceuticals
SUPN
$2.55B
| $5.19M | 0.06% |
580,000
| – | – |
|